Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC1854147

Rarecyte RareCyte RarePlex BT-474 spike-in CTC Control Slide, 10-Pack

Supplier:  Rarecyte 241247000

Encompass

A pack of ten, batch control slides to be stained, scanned, and reviewed with experimental slides. Control slides contain a monolayer of buffy coat and spiked-in BT-474 cells (epithelial cells from human breast carcinoma). This control slide is used to assess the performance of the immunofluorescent staining process for the detection of CTCs. Cells may be identified by biomarkers: Nuclear DNA, CK/EpCAM, CD45, HER2 and ER. Compatible kits: RareCyte RarePlex HER2/ER CTC Panel Kit, Ventana (SYTOX) (24-1257-002); CTC Panel Kit, Ventana (SYTOX) (24-1245-002); CTC Panel Kit, Leica (SYTOX) (24-1245-001); CTC Panel Kit, Ventana (Hoechst) (24-1277-002); CTC Panel Kit, Leica (Hoechst) (24-1277-001); CTC Panel Kit, Manual Staining (Hoechst) (24-1277-004); PD-L1 CTC Panel Kit, Ventana (24-1280-002); Developer Kit: 488 nm, Leica (28-1001-481); 405 nm, Leica (28-1001-401); 405 nm, Ventana (28-1001-402); 488 nm, Ventana(28-1001-482) and Cell Discovery Kit, Leica (24-1294-001).

Catalog No. NC1854147


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.